Biotransformations using prokaryotic P450 monooxygenases

Current Opinion in Biotechnology

Volumn 13, Issue 6, 2002, Pages 557-564

  Urlacher, Vlada ^a   Schmid, Rolf D ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CYTOCHROME P450 ISOENZYME; CYTOCHROME P450 OXYGENASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BIFUNCTIONAL REDUCTASE CYP102, BACILLUS MEGATERIUM; CAMPHOR 5 MONOOXYGENASE; CYTOCHROME P450; ELECTRON TRANSFERRING FLAVOPROTEIN; FLAVOPROTEIN; MIXED FUNCTION OXIDASE;

BIOCATALYST; BIOTRANSFORMATION; CATALYSIS; DIRECTED MOLECULAR EVOLUTION; ENZYME ANALYSIS; ENZYME ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; REVIEW; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; STEREOISOMERISM;

BACTERIA (MICROORGANISMS); PROKARYOTA;

BACTERIA; BACTERIAL PROTEINS; CAMPHOR 5-MONOOXYGENASE; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON-TRANSFERRING FLAVOPROTEINS; FLAVOPROTEINS; MIXED FUNCTION OXYGENASES; MOLECULAR STRUCTURE; MUTAGENESIS, SITE-DIRECTED; PROTEIN ENGINEERING; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036898132     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00357-9     Document Type: Review

References (53)

1. Li Z., van Beilen J.B., Duetz W.A., Schmid A., de Raadt A., Griengl H., Witholt B. Oxidative biotransformations using oxygenases. Curr Opin Chem Biol. 6:2002;136-144. This overview describes considerable progress in oxidative biotransformations using oxygenases (hydroxylation, Baeyer-Villiger oxidation, epoxidation, peroxidation and dihydroxylation).
2. Myers A.G., Siegel D.R., Buzard D.J., Charest M.G. Synthesis of a broad array of highly functionalized, enantiomerically pure cyclohexanecarboxylic acid derivatives by microbial dihydroxylation of benzoic acid and subsequent oxidative and rearrangement reactions. Org Lett. 3:2001;2923-2926.
3. Wong L.L. Cytochrome P450 monooxygenases. Curr Opin Chem Biol. 2:1998;263-268.
4. Werck-Reichhart D., Feyereisen R. Cytochromes P450: a success story. Genome Biol. 1:2000;3003. This review provides general information about gene organization, structural features, localization and function. It also gives information on the enzyme mechanism of cytochromes P450 and defines the major unsolved issues in this field.
5. Cirino P.C., Arnold F.H. Protein engineering of oxygenases for biocatalysis. Curr Opin Chem Biol. 6:2002;130-135. A new review presenting progress in the protein engineering of oxygenases. The authors give some interesting examples of changing the substrate specificity and stereoselectivity of monooxygenases, dioxygenases and chloroperoxidases.
6. Poulos T.L., Finzel B.C., Howard A.J. Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. Biochemistry. 25:1986;5314-5322.
7. Li H., Poulos T.L. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat Struct Biol. 4:1997;140-146.
8. Nakahara K., Shoun H., Adachi S., Iizuka T., Shiro Y. Crystallization and preliminary X-ray diffraction studies of nitric oxide reductase cytochrome P450nor from Fusarium oxysporum. J Mol Biol. 239:1994;158-159.
9. Hasemann C.A., Ravichandran K.G., Peterson J.A., Deisenhofer J. Crystal structure and refinement of cytochrome P450terp at 2.3 Å resolution. J Mol Biol. 236:1994;1169-1185.
10. Cupp-Vickery J.R., Poulos T.L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat Struct Biol. 2:1995;144-153.
11. Park S.Y., Yamane K., Adachi S., Shiro Y., Weiss K.E., Sligar S.G. Crystallization and preliminary X-ray diffraction analysis of a cytochrome P450 (CYP119) from Sulfolobus solfataricus. Acta Crystallogr D Biol Crystallogr. 56:2000;1173-1175.
12. Williams P.A., Cosme J., Sridhar V., Johnson E.F., McRee D.E. Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. J Inorg Biochem. 81:2000;183-190.
13. Podust L.M., Poulos T.L., Waterman M.R. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA. 98:2001;3068-3073.
14. Poulos T.L., Finzel B.C., Howard A.J. High-resolution crystal structure of cytochrome P450cam. J Mol Biol. 195:1987;687-700.
15. Yano JK, Blasco F, Li H, Schmid RD, Henne A, Poulos TL: Preliminary characterization and crystal structure of a thermostable cytochrome P450 from Thermus thermophilus. J Biol Chem 2002 Oct 24; epub ahead of print.
16. Podust LM, Waterman MR: 2.3 Å crystal structure of Streptomyces coelicolor CYP154C1: insight into diversity of macrolide monooxygenases. International Conference on Genomics, Proteomics and Bioinformatics for Medicine, 22-30 June 2002, Moscow, Russia; Abstract CO1_3.2.
17. Belkina N.V., Lisurek M., Ivanov A.S., Bernhardt R. Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. J Inorg Biochem. 87:2001;197-207.
18. Ost T.W., Miles C.S., Munro A.W., Murdoch J., Reid G.A., Chapman S.K. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3. Biochemistry. 40:2001;13421-13429.
19. Ost T.W., Munro A.W., Mowat C.G., Taylor P.R., Pesseguiero A., Fulco A.J., Cho A.K., Cheesman M.A., Walkinshaw M.D., Chapman S.K. Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM3. Biochemistry. 40:2001;13430-13438.
20. Dunn A.R., Dmochowski I.J., Bilwes A.M., Gray H.B., Crane B.R. Probing the open state of cytochrome P450cam with ruthenium-linker substrates. Proc Natl Acad Sci USA. 98:2001;12420-12425.
21. Shimizu H., Obayashi E., Gomi Y., Arakawa H., Park S.Y., Nakamura H., Adachi S., Shoun H., Shiro Y. Proton delivery in NO reduction by fungal nitric-oxide reductase. Cryogenic crystallography, spectroscopy, and kinetics of ferric-NO complexes of wild-type and mutant enzymes. J Biol Chem. 275:2000;4816-4826.
22. Li H., Poulos T.L. Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450(BM-3). Biochim Biophys Acta. 1441:1999;141-149.
23. Haines D.C., Tomchick D.R., Machius M., Peterson J.A. Pivotal role of water in the mechanism of P450BM-3. Biochemistry. 40:2001;13456-13465. This paper describes the crystal structure of P45BM-3 with bound N-palmitoylglycine at a resolution of 1.65 Å. Such a high resolution allows us to understand the early steps of catalysis in P450s and revealed the role of a water molecule in substrate binding.
24. Lee D.S., Yamada A., Matsunaga I., Ichihara K., Adachi S., Park S.Y., Shiro Y. Crystallization and preliminary X-ray diffraction analysis of fatty-acid hydroxylase cytochrome P450BSβ from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr. 58:2002;687-689.
25. Matsunaga I., Ueda A., Sumimoto T., Ichihara K., Ayata M., Ogura H. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450. Arch Biochem Biophys. 394:2001;45-53.
26. Unno M., Christian J.F., Sjodin T., Benson D.E., Macdonald I.D., Sligar S.G., Champion P.M. Complex formation of cytochrome P450cam with putidaredoxin. Evidence for protein-specific interactions involving the proximal thiolate ligand. J Biol Chem. 277:2002;2547-2553.
27. Djuricic D., Hill H.A., Lo K.K., Wong L.L. A scanning tunneling microscopy (STM) investigation of complex formation between cytochrome P450(cam) and putidaredoxin. J Inorg Biochem. 88:2002;362-367.
28. Sevrioukova I.F., Hazzard J.T., Tollin G., Poulos T.L. The FMN to heme electron transfer in cytochrome P450BM-3. Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site. J Biol Chem. 274:1999;36097-36106.
29. Koo L.S., Immoos C.E., Cohen M.S., Farmer P.J., Ortiz De Montellano P.R. Enhanced electron transfer and lauric acid hydroxylation by site-directed mutagenesis of CYP119. J Am Chem Soc. 124:2002;5684-5691. The hydroxylation of lauric acid by the P450 enzyme from S. solfotaricus was supported by electron transfer from putidaredoxin reductase and putidaredoxin. This fatty acid activity was increased by site-directed mutagenesis, which increased putidaredoxin binding.
30. Gilardi G., Meharenna Y.T., Tsotsou G.E., Sadeghi S.J., Fairhead M., Giannini S. Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology. Biosens Bioelectron. 17:2002;133-145. Demonstration of the successful application of the molecular Lego approach to P450 enzymes with three objectives: to build an artificial multidomain redox chain, to construct soluble human P450 enzyme, and to create a library of new P459 BM-3 mutants.
31. Lei C., Wollenberger U., Jung C., Scheller F.W. Clay-bridged electron transfer between cytochrome p450(cam) and electrode. Biochem Biophys Res Commun. 268:2000;740-744.
32. Faulkner K.M., Shet M.S., Fisher C.W., Estabrook R.W. Electrocatalytically driven ω-hydroxylation of fatty acids using cytochrome P450 4A1. Proc Natl Acad Sci USA. 92:1995;7705-7709.
33. Schwaneberg U., Appel D., Schmitt J., Schmid R.D. P450 in biotechnology: zinc driven ω-hydroxylation of π-nitrophenoxydodecanoic acid using P450 BM-3 F87A as a catalyst. J Biotechnol. 84:2000;249-257. This paper describes the application of zinc dust for the regeneration of the mediator cobalt sepulchrate, which can replace the NADPH cofactor.
34. Shumyantseva V.V., Bulko T.V., Schmid R.D., Archakov A.I. Photochemical properties of a riboflavins/cytochrome P450 2B4 complex. Biosens Bioelectron. 17:2002;233-238. Very interesting example in which the photochemical properties of riboflavins are used to obtain a non-covalent complex with one artificial flavocytochrome P4502B4. After the introduction of the flavin residue the cytochrome P450 enzyme can be used as a photodiode or photoreceptor.
35. Schwaneberg U., Schmidt-Dannert C., Schmitt J., Schmid R.D. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A. Anal Biochem. 269:1999;359-366.
36. Schwaneberg U., Otey C., Cirino P.C., Farinas E., Arnold F.H. Cost-effective whole-cell assay for laboratory evolution of hydroxylases in Escherichia coli. J Biomol Screen. 6:2001;111-117.
37. Tsotsou G.E., Cass A.E., Gilardi G. High-throughput assay for cytochrome P450 BM3 for screening libraries of substrates and combinatorial mutants. Biosens Bioelectron. 17:2002;119-131.
38. Li Q.S., Ogawa J., Schmid R.D., Shimizu S. Residue size at position 87 of cytochrome P450 BM-3 determines its stereoselectivity in propylbenzene and 3-chlorostyrene oxidation. FEBS Lett. 508:2001;249-252.
39. Lentz O., Li Q.-S., Schwaneberg U., Lutz-Wahl S., Fischer P., Schmid R.D. Modification of the fatty acid specificity of cytochrome P450BM-3 from Bacillus megaterium by directed evolution: a validated assay. J Mol Catal B Enzym. 15:2001;123-133.
40. Appel D., Lutz-Wahl S., Fischer P., Schwaneberg U., Schmid R.D. A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes. J Biotechnol. 88:2001;167-171. Short report about the extraordinary substrate specificity of a CYP102 mutant.
41. Bell S.G., Harford-Cross C.F., Wong L.L. Engineering the CYP101 system for in vivo oxidation of unnatural substrates. Protein Eng. 14:2001;797-802. This paper describes a functional in vivo catalytic system based on CYP101 and its cofactor proteins and indicates the great facility of this system for directed evolution of CYP101. The authors report the construction of new mutants with enhanced activity for unusual substrates.
42. French K.J., Strickler M.D., Rock D.A., Bennett G.A., Wahlstrom J.L., Goldstein B.M., Jones J.P. Benign synthesis of 2-ethylhexanoic acid by cytochrome P450cam: enzymatic, crystallographic, and theoretical studies. Biochemistry. 40:2001;9532-9538.
43. French K.J., Rock D.A., Manchester J.I., Goldstein B.M., Jones J.P. Active site mutations of cytochrome p450cam alter the binding, coupling, and oxidation of the foreign substrates (R)- and (S)-2-ethylhexanol. Arch Biochem Biophys. 398:2002;188-197.
44. Li Q.S., Schwaneberg U., Fischer M., Schmitt J., Pleiss J., Lutz-Wahl S., Schmid R.D. Rational evolution of a medium-chain-specific cytochrome P-450 BM-3 variant. Biochim Biophys Acta. 1545:2001;114-121.
45. Farinas E.T., Schwaneberg U., Glieder A., Arnold F.H. Directed evolution of a cytochrome P450 monooxygenase for alkane oxidation. Adv Synth Catal. 343:2001;601-606.
46. Wilson E.K. Prospecting for proteins. Chem Eng News. 17:2001;49-51.
47. Li Q.S., Schwaneberg U., Fischer P., Schmid R.D. Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst. Chemistry. 6:2000;1531-1536.
48. Shou M., Gonzalez F.J., Gelboin H.V. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. Biochemistry. 35:1996;15807-15813.
49. Harford-Cross C.F., Carmichael A.B., Allan F.K., England P.A., Rouch D.A., Wong L.L. Protein engineering of cytochrome p450(cam) (CYP101) for the oxidation of polycyclic aromatic hydrocarbons. Protein Eng. 13:2000;121-128.
50. Carmichael A.B., Wong L.L. Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. Eur J Biochem. 268:2001;3117-3125. Using the protein engineering of P450 BM-3, new biocatalysts have been obtained with improved activity for PAH oxidation. Structural changes during substrate binding have been analyzed and the effect of different mutations on NADPH turnover and coupling efficiency has been described.
51. Li Q.S., Ogawa J., Schmid R.D., Shimizu S. Engineering cytochrome P450 BM-3 for oxidation of polycyclic aromatic hydrocarbons. Appl Environ Microbiol. 67:2001;5735-5739.
52. Joo H., Lin Z., Arnold F.H. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature. 399:1999;670-673.
53. Glieder A., Farinas E.T., Arnold F.H. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nat Biotechnol. 20:2002;1135-1139.